DK2432766T3 - Anticancerforbindelse og farmaceutisk præparat, der indeholder den - Google Patents

Anticancerforbindelse og farmaceutisk præparat, der indeholder den

Info

Publication number: DK2432766T3
Authority: DK; Denmark
Prior art keywords: pharmaceutical composition; composition containing; anticancer compound; anticancer; compound
Prior art date: 2009-05-18

Application number

DK10728768.2T

Other languages

English (en)

Inventor

Jean-Christophe Carry

Michel Cheve

Cecile Combeau

Sylvie Gontier

Alain Krick

Sylvette Lachaud

Laurent Schio

Franacois Clerc

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-18

Filing date

2010-05-17

Publication date

2013-10-28

2010-05-17 Application filed by Sanofi Sa filed Critical Sanofi Sa

2013-10-28 Application granted granted Critical

2013-10-28 Publication of DK2432766T3 publication Critical patent/DK2432766T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK10728768.2T 2009-05-18 2010-05-17 Anticancerforbindelse og farmaceutisk præparat, der indeholder den DK2432766T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0902392A FR2945535B1 (fr)	2009-05-18	2009-05-18	Compose anticancereux et composition pharmaceutique le contenant
PCT/FR2010/050948 WO2010133794A1 (fr)	2009-05-18	2010-05-17	Compose anticancéreux et composition pharmaceutique le contenant

Publications (1)

Publication Number	Publication Date
DK2432766T3 true DK2432766T3 (da)	2013-10-28

Family

ID=40973187

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK10728768.2T DK2432766T3 (da)	2009-05-18	2010-05-17	Anticancerforbindelse og farmaceutisk præparat, der indeholder den

Country Status (35)

Country	Link
US (2)	US9073917B2 (da)
EP (1)	EP2432766B1 (da)
JP (1)	JP5656981B2 (da)
KR (1)	KR20120032483A (da)
CN (1)	CN102459193B (da)
AR (1)	AR076686A1 (da)
AU (1)	AU2010251013B2 (da)
BR (1)	BRPI1012201A2 (da)
CA (1)	CA2762233C (da)
CL (1)	CL2011002930A1 (da)
CO (1)	CO6400138A2 (da)
CY (1)	CY1114850T1 (da)
DK (1)	DK2432766T3 (da)
EA (1)	EA021084B1 (da)
ES (1)	ES2430989T3 (da)
FR (1)	FR2945535B1 (da)
HK (1)	HK1167388A1 (da)
HR (1)	HRP20130959T1 (da)
IL (1)	IL216361A0 (da)
JO (1)	JO2852B1 (da)
MA (1)	MA33356B1 (da)
ME (1)	ME01542B (da)
MX (1)	MX2011012356A (da)
MY (1)	MY152995A (da)
NZ (1)	NZ596464A (da)
PL (1)	PL2432766T3 (da)
PT (1)	PT2432766E (da)
RS (1)	RS53002B (da)
SG (1)	SG176169A1 (da)
SI (1)	SI2432766T1 (da)
SM (1)	SMT201400005B (da)
TW (1)	TWI441822B (da)
UY (1)	UY32644A (da)
WO (1)	WO2010133794A1 (da)
ZA (1)	ZA201108447B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2945535B1 (fr)	2009-05-18	2011-06-10	Sanofi Aventis	Compose anticancereux et composition pharmaceutique le contenant
FR2967413A1 (fr) *	2010-11-17	2012-05-18	Sanofi Aventis	Compose 8-oxo-9-[3-(1h-benzimidazol-2-yloxy)-phenyl]-4,5,6,7,8,9-hexahydro-2h-pyrrolo[3,4-b]quinoline-3-carboxylate d'ethyle, sel, forme cristalline, co-cristal, formulation, procedes de preparation, application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteur des kinases aurora.
EP2909204B1 (en)	2012-10-12	2018-12-05	The Broad Institute, Inc.	Gsk3 inhibitors and methods of use thereof
EP3164388A1 (en)	2014-07-01	2017-05-10	Takeda Pharmaceutical Company Limited	Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors
AU2018249558A1 (en)	2017-04-05	2019-11-07	Biogen Ma Inc.	Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
WO2024229406A1 (en)	2023-05-04	2024-11-07	Revolution Medicines, Inc.	Combination therapy for a ras related disease or disorder
US20250049810A1 (en)	2023-08-07	2025-02-13	Revolution Medicines, Inc.	Methods of treating a ras protein-related disease or disorder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003529552A (ja)	1999-11-19	2003-10-07	アボット・ラボラトリーズ	三環性ジヒドロピリミジンカリウムチャンネル開口剤
CA2437215A1 (en)	2001-02-02	2002-08-15	Mitsubishi Pharma Corporation	Dihydropyrazolopyridine compounds and pharmaceutical use thereof
US7037902B2 (en)	2002-07-03	2006-05-02	Receptron, Inc.	Affinity small molecules for the EPO receptor
WO2005016245A2 (en) *	2003-06-13	2005-02-24	Zentaris Gmbh	Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof
ES2339676T3 (es) *	2005-07-20	2010-05-24	Aventis Pharma S.A.	Heterociclicos condensados con 1,4-dihidropiridina, procedimiento par a prepararlos, uso y composiciones que los contienen.
FR2945535B1 (fr)	2009-05-18	2011-06-10	Sanofi Aventis	Compose anticancereux et composition pharmaceutique le contenant

2009
- 2009-05-18 FR FR0902392A patent/FR2945535B1/fr not_active Expired - Fee Related
2010
- 2010-05-16 JO JO2010163A patent/JO2852B1/en active
- 2010-05-17 PL PL10728768T patent/PL2432766T3/pl unknown
- 2010-05-17 PT PT107287682T patent/PT2432766E/pt unknown
- 2010-05-17 MX MX2011012356A patent/MX2011012356A/es active IP Right Grant
- 2010-05-17 AR ARP100101705A patent/AR076686A1/es unknown
- 2010-05-17 US US13/320,965 patent/US9073917B2/en not_active Expired - Fee Related
- 2010-05-17 CN CN201080032327.7A patent/CN102459193B/zh not_active Expired - Fee Related
- 2010-05-17 RS RS20130444A patent/RS53002B/en unknown
- 2010-05-17 MA MA34441A patent/MA33356B1/fr unknown
- 2010-05-17 ME MEP-2013-121A patent/ME01542B/me unknown
- 2010-05-17 AU AU2010251013A patent/AU2010251013B2/en not_active Ceased
- 2010-05-17 DK DK10728768.2T patent/DK2432766T3/da active
- 2010-05-17 CA CA2762233A patent/CA2762233C/fr not_active Expired - Fee Related
- 2010-05-17 EP EP10728768.2A patent/EP2432766B1/fr active Active
- 2010-05-17 WO PCT/FR2010/050948 patent/WO2010133794A1/fr active Application Filing
- 2010-05-17 EA EA201171429A patent/EA021084B1/ru not_active IP Right Cessation
- 2010-05-17 TW TW099115713A patent/TWI441822B/zh not_active IP Right Cessation
- 2010-05-17 BR BRPI1012201A patent/BRPI1012201A2/pt not_active IP Right Cessation
- 2010-05-17 ES ES10728768T patent/ES2430989T3/es active Active
- 2010-05-17 NZ NZ596464A patent/NZ596464A/en not_active IP Right Cessation
- 2010-05-17 JP JP2012511323A patent/JP5656981B2/ja not_active Expired - Fee Related
- 2010-05-17 SI SI201030384T patent/SI2432766T1/sl unknown
- 2010-05-17 SG SG2011085529A patent/SG176169A1/en unknown
- 2010-05-17 MY MYPI2011005531 patent/MY152995A/en unknown
- 2010-05-17 KR KR1020117030136A patent/KR20120032483A/ko not_active Withdrawn
- 2010-05-18 UY UY0001032644A patent/UY32644A/es not_active Application Discontinuation
2011
- 2011-11-14 IL IL216361A patent/IL216361A0/en unknown
- 2011-11-17 ZA ZA2011/08447A patent/ZA201108447B/en unknown
- 2011-11-18 CL CL2011002930A patent/CL2011002930A1/es unknown
- 2011-11-18 CO CO11157425A patent/CO6400138A2/es active IP Right Grant
2012
- 2012-08-15 HK HK12108002.5A patent/HK1167388A1/xx not_active IP Right Cessation
2013
- 2013-10-09 HR HRP20130959AT patent/HRP20130959T1/hr unknown
- 2013-10-17 CY CY20131100920T patent/CY1114850T1/el unknown
2014
- 2014-01-16 SM SM201400005T patent/SMT201400005B/xx unknown
2015
- 2015-06-02 US US14/728,846 patent/US9221817B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2010133794A1 (fr)	2010-11-25
FR2945535A1 (fr)	2010-11-19
US9221817B2 (en)	2015-12-29
CN102459193B (zh)	2014-08-27
AU2010251013B2 (en)	2015-08-20
BRPI1012201A2 (pt)	2016-04-05
SG176169A1 (en)	2011-12-29
ME01542B (me)	2014-04-20
JP2012527436A (ja)	2012-11-08
PL2432766T3 (pl)	2013-12-31
CN102459193A (zh)	2012-05-16
KR20120032483A (ko)	2012-04-05
EA021084B1 (ru)	2015-04-30
ZA201108447B (en)	2013-01-30
EA201171429A1 (ru)	2012-05-30
CL2011002930A1 (es)	2012-06-29
AU2010251013A1 (en)	2011-12-08
UY32644A (es)	2010-12-31
HRP20130959T1 (hr)	2013-11-22
JP5656981B2 (ja)	2015-01-21
NZ596464A (en)	2014-01-31
PT2432766E (pt)	2013-10-23
EP2432766B1 (fr)	2013-07-17
CO6400138A2 (es)	2012-03-15
SI2432766T1 (sl)	2013-11-29
RS53002B (en)	2014-04-30
CA2762233C (fr)	2017-11-28
TWI441822B (zh)	2014-06-21
JO2852B1 (en)	2015-03-15
US20150266877A1 (en)	2015-09-24
MY152995A (en)	2014-12-31
CA2762233A1 (fr)	2010-11-25
FR2945535B1 (fr)	2011-06-10
MX2011012356A (es)	2011-12-14
AR076686A1 (es)	2011-06-29
EP2432766A1 (fr)	2012-03-28
US20120220621A1 (en)	2012-08-30
CY1114850T1 (el)	2016-12-14
ES2430989T3 (es)	2013-11-22
US9073917B2 (en)	2015-07-07
MA33356B1 (fr)	2012-06-01
SMT201400005B (it)	2014-03-07
IL216361A0 (en)	2012-01-31
HK1167388A1 (en)	2012-11-30
TW201100418A (en)	2011-01-01

Publication	Publication Date	Title
BRPI1010772A2 (pt)	2016-11-01	composto,e, composição farmacêutica.
SMT201700095B (is)	2017-03-08	Composizioni farmaceutiche per inalazione
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
DK3097925T3 (da)	2019-08-05	Farmaceutisk sammensætning
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
BRPI1009372A2 (pt)	2016-05-31	compostos, composição farmacêutica e respectivos usos
DK3812360T3 (da)	2024-01-15	Monochlortrifluorpropen forbindelser og sammensætninger og metoder, der anvender dem
IL214175A (en)	2015-09-24	Derivatives of aminotetralin, their pharmaceutical compositions and their use
BRPI1004940A2 (pt)	2018-06-19	composição farmacêutica
LT3061445T (lt)	2023-09-25	Labai koncentruotos farmacinės kompozicijos
LT3360575T (lt)	2023-06-12	Transderminės farmacinės kompozicijos, apimančios veiksminguosius agentus
BR112012011902A2 (pt)	2017-10-10	cápsula farmacêutica
BRPI1012539A2 (pt)	2016-03-29	composições farmacêuticas
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
BRPI1015939A2 (pt)	2016-09-27	composição farmacêutica
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados
BRPI0909738A2 (pt)	2015-10-06	composições farmacêuticas aquosas contendo complexos de boratopoliol
DK2391349T3 (da)	2014-11-03	Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
DK2254873T3 (da)	2014-06-30	Benzodiazepinforbindelse og farmaceutisk sammensætning.
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
IT1394400B1 (it)	2012-06-15	Composizioni farmaceutiche
DK2285357T3 (da)	2014-06-02	Farmaceutisk sammensætning omfattende brivaracetam
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat